ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases.
作者信息
Ikizler T Alp, Kramer Holly J, Beddhu Srinivasan, Chang Alex R, Friedman Allon N, Harhay Meera N, Jimenez Elizabeth Yakes, Kistler Brandon, Kukla Aleksandra, Larson Kristin, Lavenburg LindaMarie U, Navaneethan Sankar Dass, Ortiz John, Pereira Rocio I, Sarwer David B, Schauer Philip R, Zeitler Evan M
机构信息
Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Nephrology and Hypertension, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.
出版信息
J Am Soc Nephrol. 2024 Nov 1;35(11):1574-1588. doi: 10.1681/ASN.0000000512. Epub 2024 Sep 18.
Abstract
摘要
相似文献
1
ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases.
J Am Soc Nephrol. 2024 Nov 1;35(11):1574-1588. doi: 10.1681/ASN.0000000512. Epub 2024 Sep 18.
2
SEN, SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification.
Kidney Int. 2025 Jul 3. doi: 10.1016/j.kint.2025.06.013.
3
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
BMJ. 2024 Oct 1;387:e080257. doi: 10.1136/bmj-2024-080257.
4
A Systematic Review of Barriers and Facilitators of Pain Management in Persons with Dementia.
J Pain. 2023 May;24(5):730-741. doi: 10.1016/j.jpain.2022.12.014. Epub 2023 Jan 9.
5
Improving Diet Quality of People Living With Obesity by Building Effective Dietetic Service Delivery Using Technology in a Primary Health Care Setting: Protocol for a Randomized Controlled Trial.
JMIR Res Protoc. 2025 Apr 30;14:e64735. doi: 10.2196/64735.
7
"It doesn't get more normal than that!" - challenges with sexuality experienced by people with neuromuscular diseases and their needs for rehabilitation knowledge and guidance on sexual life.
Disabil Rehabil. 2025 Aug;47(16):4127-4136. doi: 10.1080/09638288.2024.2440635. Epub 2024 Dec 18.
8
Gender-affirming Hormone Therapy and Changes in Kidney Function in Adults: A Retrospective Population-based Study.
Kidney Med. 2025 Jun 17;7(8):101051. doi: 10.1016/j.xkme.2025.101051. eCollection 2025 Aug.
9
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.
10
Digital health, technology-driven or technology-assisted interventions for the management of obesity in children and adolescents.
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015968. doi: 10.1002/14651858.CD015968.
引用本文的文献
1
Low-Energy Diets: Potential Treatment Option for Patients With Obesity and Early-Stage CKD?
Kidney Int Rep. 2025 May 17;10(7):2088-2090. doi: 10.1016/j.ekir.2025.05.018. eCollection 2025 Jul.
2
Practices in the management of kidney transplant candidates and recipients with obesity: A survey of United States transplant programs.
Am J Transplant. 2025 May 31. doi: 10.1016/j.ajt.2025.05.033.
3
Obesity and its management in primary care setting.
J Diabetes Complications. 2025 Jul;39(7):109045. doi: 10.1016/j.jdiacomp.2025.109045. Epub 2025 Apr 19.
4
Obesity and Metabolic Health in CKD.
Clin J Am Soc Nephrol. 2025 May 1;20(5):742-754. doi: 10.2215/CJN.0000000704. Epub 2025 Mar 14.
本文引用的文献
1
Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients with Established Kidney Disease.
Ann Surg. 2024 Sep 1;280(3):414-423. doi: 10.1097/SLA.0000000000006379. Epub 2024 Jun 11.
2
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial.
Nat Med. 2024 Jul;30(7):2058-2066. doi: 10.1038/s41591-024-03015-5. Epub 2024 May 25.
3
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24.
4
Weight Loss Surgery Increases Kidney Transplant Rates in Patients With Renal Failure and Obesity.
Mayo Clin Proc. 2024 May;99(5):705-715. doi: 10.1016/j.mayocp.2024.01.017.
5
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
6
Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.
JAMA. 2024 Feb 27;331(8):654-664. doi: 10.1001/jama.2024.0318.
7
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
J Am Soc Nephrol. 2024 Feb 1;35(2):202-215. doi: 10.1681/ASN.0000000000000271. Epub 2023 Dec 12.
8
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S179-S218. doi: 10.2337/dc24-S010.
9
Nutritional Considerations for Patients With Renal Failure Undergoing Sleeve Gastrectomy.
J Ren Nutr. 2024 Jan;34(1):76-86. doi: 10.1053/j.jrn.2023.08.005. Epub 2023 Aug 19.
10
Comparative outcomes of bariatric surgery in patients with ESRD on dialysis in the modern era of renal transplantation: analysis using the 2015-2020 MBSAQIP database.
Surg Endosc. 2023 Sep;37(9):7106-7113. doi: 10.1007/s00464-023-10200-z. Epub 2023 Jul 3.
Zotero 插件